116.15 0.00 (0.00%)
After hours: 5:02PM EDT
|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||115.61 - 117.07|
|52 Week Range||114.01 - 150.40|
|PE Ratio (TTM)||19.16|
|Earnings Date||May 2, 2018|
|Forward Dividend & Yield||3.84 (3.02%)|
|1y Target Est||139.07|
Clorox's (CLX) weak margin in the last reported quarter is expected to continue in the fiscal third quarter. However, the company's approach toward brand management and Go Lean strategy are impressive.
OAKLAND, Calif. , April 26, 2018 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that Chief Executive Officer Benno Dorer and Chief Financial Officer Kevin Jacobsen will be featured speakers ...
Kimberly-Clark (KMB) reported an improved sales and earnings performance in 1Q18. The company surpassed analysts’ expectations both on the sales and EPS fronts. However, continued pressure on margins, promotional spending to drive volumes, and lower pricing remained a drag and continued to hurt its margins. The company’s gross margin fell significantly in 1Q18, which prompted a couple of analysts to lower the target price on Kimberly-Clark stock. Jefferies lowered its price target to $102 per share from $110. Meanwhile, Wells Fargo reduced its target price on KMB stock to $92 from $100.
The home and personal care product manufacturers in the US continue to disappoint with their margin performance. Significant inflation in commodities, promotional spending to drive volumes, lower net price realization, and a tough retail environment are taking a toll on the profit margins of the companies operating in this space.
Kimberly-Clark (KMB) sustained its sales momentum in 1Q18. The company’s net sales of $4.7 billion exceeded analysts’ expectations and increased 5.1% on a YoY (year-over-year) basis thanks to the favorable currency rates, which contributed about 3.0% to the top-line growth rate. Plus, investments in brands to support volumes dented the net sales growth rate.
Kimberly-Clark (KMB) reported stronger-than-expected 1Q18 earnings. Kimberly-Clark’s adjusted earnings of $1.71 per share came in ahead of the consensus estimate of $1.69 and rose 8.9% on a YoY (year-over-year) basis. The company has now surpassed analysts’ expectations in three quarters despite pressure on margins from significant inflation in input costs and lower net price realization.
Kimberly-Clark (KMB) reported better-than-expected 1Q18 results on Monday, April 23, 2018. The company’s top-line and bottom-line results surpassed analysts’ expectations. However, investors didn’t care much, and the company’s stock fell about 1.5% as persisting challenges, especially on the margins front, remained a drag.
Most analysts covering Church & Dwight (CHD) stock have recommended “hold,” despite the company’s strong sales and earnings performance in the past two quarters and upbeat guidance. Church & Dwight’s sales and adjusted earnings grew by double digits during the last reported quarter, and they are expected to sustain that momentum in 1Q18.
Analysts expect Church & Dwight (CHD) to report strong sales and earnings growth in the upcoming quarter. Church & Dwight is expected to announce its 1Q18 results on May 3, 2018, and analysts expect the company’s top line to rise 11.5% YoY (year-over-year), more than peers’.
Church & Dwight (CHD) stock fell ~6% on Friday, April 20, 2018, after being downgraded by Deutsche Bank to “hold” from “buy.” Its price target was lowered to $50 per share from $56. Investors are skeptical on the prospects of household and personal care product manufacturers, which are facing increased price competition, a challenging retail scenario, and margin headwinds.
LONDON, UK / ACCESSWIRE / April 23, 2018 / Active-Investors has a free review on The Clorox Co. (NYSE: CLX) following the Company's announcement that it will begin trading ex-dividend on April 24, 2018. Active-Investors has initiated due-diligence on this dividend stock. If your portfolio includes dividend stocks, you have come to the right place for timely information.
Procter and Gamble (PG) saw improved sales and earnings performance in fiscal 3Q18. The company’s top and bottom line surpassed analysts’ expectations. However, the company’s soft organic sales growth rate and sluggish margins due to lower pricing and increased costs didn’t sit well with analysts.
Procter & Gamble (PG) continued to report sluggish margins in fiscal 3Q18. The company’s core gross margin fell 110 basis points to 49.4% in fiscal 3Q18 as lower pricing to drive volumes and increased cost pressure more than offset the benefits stemming from cost and productivity savings.
Procter & Gamble (PG) reported net sales of $16.3 billion, a rise of 4.3% YoY (year-over-year), which exceeded analysts’ expectations. As expected, Procter & Gamble’s top line benefitted from improved volumes and favorable currency rates. Also, the improved mix contributed 1% to the net sales growth rate.
Procter & Gamble (PG) reported adjusted earnings of $1.00 per share in fiscal 3Q18, which came in ahead of analysts’ estimate of $0.98 and increased 4.2% YoY (year-over-year). Moreover, Procter & Gamble has now surpassed analysts’ earnings expectations in the past 12 quarters. However, what didn’t sit well with investors was the company’s low EPS growth rate, especially given the benefits from favorable currency rates, the low tax rate environment, and strong productivity savings.
Most of the analysts covering Colgate-Palmolive (CL) have maintained “hold” ratings on its stock as a soft sales environment, a moderating category growth rate, increased competition, and margin headwinds have kept them on the sidelines.
NEW YORK, NY / ACCESSWIRE / April 20, 2018 / The Clorox Company and Procter & Gamble both sank to new lows on Thursday. The Clorox company saw its shares decrease after a downgrade from a Morgan Stanley ...
As for Colgate-Palmolive (CL), the company’s profit margins are likely to be adversely impacted by inflation in commodity prices, including resins and pulp. Higher logistics costs and increased advertising spending to support new product launches and drive market share are also expected to hurt its margins. Higher volumes, a focus on productivity savings, and SKU optimization are likely to support its margins.
Analysts expect Colgate-Palmolive (CL) to report sales of $4.0 billion in 1Q18, which represents a YoY (year-over-year) rise of 6.6%. The graph above shows that Colgate-Palmolive’s sales are showing an improving trend thanks to favorable currency rates and improvements in its volumes. Colgate-Palmolive’s top line is likely to benefit from improvements in volumes driven by new product launches in the oral and personal care segments backed by increased investments in advertising.
Colgate-Palmolive’s (CL) earnings have remained flat over the past two quarters as benefits from currency tailwinds, improved volumes, and cost savings have been offset by higher raw material and packaging costs, lower pricing, and advertising spending. What could drive Colgate-Palmolive’s 1Q18 EPS? Colgate-Palmolive’s bottom line is expected to benefit from an improvement in its volumes.
Procter & Gamble Co (NYSE:PG) stock took a hit following its earnings announcement. Although the company beat on both revenue and net income, earnings guidance disappointed Wall Street. Most of its peers in the consumer defensive sector also saw stock price drops on slower-than-expected growth.
Colgate-Palmolive (CL) is set to announce its 1Q18 earnings on April 27, 2018. Analysts expect the company’s top line to continue to improve driven by higher volumes and increased market share. New product launches and higher advertising spending are likely to support the company’s volumes.
Morgan Stanley's Dara Mohsenian cuts his rating on Clorox to underweight from equal weight and slashed his price target to $116 a share from $128. Mohsenian says some of the challenges Clorox faces are pricing pressures and a shift away from "large established brands towards smaller brands" by consumers. Given these factors, "we believe consensus expectations for CLX are too high on both organic sales growth and gross margins over the next few years," Mohsenian notes.
Packaged food, beverages, tobacco and the rest of consumer staples haven't rewarded investors lately (but don't say we didn't warn you). Today, big household product makers are weighing on the sector. Procter & Gamble (PG) is falling on Thursday following its fiscal third-quarter earnings report. The maker of personal-care products earned $1 a share, a penny ahead of estimates, while revenue climbed 4.3% year-over-year to $16.28 billion, squeaking past the $16.22 billion consensus estimate.